RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Alar Pharmaceuticals Stock

Alar Pharmaceuticals P/E 2025

Alar Pharmaceuticals P/E

340.33

Ticker

6785.TWO

ISIN

TW0006785009

As of Jan 12, 2025, Alar Pharmaceuticals's P/E ratio was 340.33, a 77.13% change from the 192.14 P/E ratio recorded in the previous year.

The Alar Pharmaceuticals P/E history

Alar Pharmaceuticals Aktienanalyse

What does Alar Pharmaceuticals do?

Alar Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Alar Pharmaceuticals's P/E Ratio

The Price to Earnings (P/E) Ratio of Alar Pharmaceuticals is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Alar Pharmaceuticals's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Alar Pharmaceuticals is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Alar Pharmaceuticals’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Alar Pharmaceuticals stock

What is the price-to-earnings ratio of Alar Pharmaceuticals?

The price-earnings ratio of Alar Pharmaceuticals is currently 340.33.

How has the price-earnings ratio of Alar Pharmaceuticals changed compared to last year?

The price-to-earnings ratio of Alar Pharmaceuticals has increased by 77.13% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Alar Pharmaceuticals high compared to other companies?

Yes, the price-to-earnings ratio of Alar Pharmaceuticals is high compared to other companies.

How does an increase in the price-earnings ratio of Alar Pharmaceuticals affect the company?

An increase in the price-earnings ratio of Alar Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Alar Pharmaceuticals affect the company?

A decrease in the price-earnings ratio of Alar Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Alar Pharmaceuticals?

Some factors that influence the price-earnings ratio of Alar Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Alar Pharmaceuticals pay?

Over the past 12 months, Alar Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Alar Pharmaceuticals is expected to pay a dividend of 6 TWD.

What is the dividend yield of Alar Pharmaceuticals?

The current dividend yield of Alar Pharmaceuticals is .

When does Alar Pharmaceuticals pay dividends?

Alar Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Alar Pharmaceuticals?

Alar Pharmaceuticals paid dividends every year for the past 2 years.

What is the dividend of Alar Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 6 TWD are expected. This corresponds to a dividend yield of 3.95 %.

In which sector is Alar Pharmaceuticals located?

Alar Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Alar Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Alar Pharmaceuticals from 6/28/2024 amounting to 1.5 TWD, you needed to have the stock in your portfolio before the ex-date on 6/5/2024.

When did Alar Pharmaceuticals pay the last dividend?

The last dividend was paid out on 6/28/2024.

What was the dividend of Alar Pharmaceuticals in the year 2024?

In the year 2024, Alar Pharmaceuticals distributed 0 TWD as dividends.

In which currency does Alar Pharmaceuticals pay out the dividend?

The dividends of Alar Pharmaceuticals are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Alar Pharmaceuticals

Our stock analysis for Alar Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Alar Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.